Invokana® (canagliflozin), Invokamet/Invokamet® XR (canagliflozin/metformin) – Expanded indication
December 18, 2024 - The FDA approved Janssen’s Invokana (canagliflozin) and Invokamet/Invokamet XR (canagliflozin/metformin), as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
Top